Bit rubbish that these companies are trying to claim they are SaaS companies and have 'recurring' revenues, but can't even provide a guidance (range).
Also claim investment in international markets with a view to a return, but again can't quantify any of that.....sure no one knows for certain, but again a range and timing
poor mgmt IMO!!
Ann: MedAdvisor 2020 Annual Report & Appendix 4E, page-5
-
- There are more pages in this discussion • 11 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MDR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
45.5¢ |
Change
0.010(2.25%) |
Mkt cap ! $250.8M | |||
| Open | High | Low | Value | Volume |
| 44.5¢ | 45.5¢ | 44.5¢ | $683.4K | 1.508M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 7000 | 45.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 45.5¢ | 34999 | 1 |
View Market Depth
| Last trade - 16.10pm 20/08/2024 (20 minute delay) ? |
| MDR (ASX) Chart |